Unigen(TM) Signs Licensing Agreement For Univestin(TM) With Basic Research

Companies Collaborate To Further Market Univestin

BROOMFIELD, CO--Unigen(TM) Pharmaceuticals, Inc., and Basic Research, Inc., announced that the two companies have concluded a licensing agreement for Unigen¹s proprietary, patent pending dietary supplement Univestin(TM). Under the multiple-year agreement, Basic Research has exclusive rights to market Univestin to the retail health food, magazine and infomercial marketing channels.

"Our collaboration with Basic Research provides an avenue to build upon our success in the industry," stated Regan Miles, vice president of sales and marketing for Unigen Pharmaceuticals, Inc. "This agreement further expands Unigen¹s presence while fulfilling the demand for Univestin."

Univestin is Unigen¹s proprietary, patent pending dietary supplement ingredient that has been in development for over four years. It is a botanical compound that is comprised of all natural plant sources. Univestin is scientifically proven fast, efficacious and safe in helping to promote increased mobility and healthy joint function. Univestin is currently involved in a major, IRB approved, double blind and placebo controlled human clinical trial in Montreal, Canada.

"Basic Research is pleased to partner with such an innovative company and capitalize on our respective strengths," stated Dennis Gay, CEO for Basic Research. "This relationship brings together two market leaders in their respective fields to offer solutions that meet the needs of our consumers."

The agreement marks another step in Unigen¹s bid to create awareness of Univestin in the market. Under the agreement, countries covered include USA, Canada, Mexico, Japan, Pakistan and the European Union for the licensed channels.

Unigen(TM) Pharmaceuticals, Inc.
Unigen Pharmaceuticals, Inc. is a leading natural products research and development facility and proprietary ingredients supplier. They are dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Unigen (http://www.unigenpharma.com.), and sister company Aloecorp, are subsidiaries of the Univera Group of companies. Each company focuses on identifying and studying the unique ingredients of medicinal botanicals and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.

Basic Research, Inc.
Basic Research, Inc., is a weight-loss, joint-health and sports nutrition industry leader. For nearly ten years, Basic Research companies have been applauded as innovators in the weight-control industry. It has enjoyed coveted industry accolades such as "Best Up and Coming Product" and "Best Seller" from Whole Foods, and three consecutive awards of "The Silver Vity" from Vitamin Retailer magazine.

Basic Research and its family of companies are poised to provide unique, clinically proven weight management products at an affordable price. For more information on Basic Research visit http://www.basicresearch.org.

# # #


Regan Miles
Unigen Pharmaceuticals, Inc.
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.